Amir Almasi-Hashiani

Amir Almasi-Hashiani

Auto-generated profile, based on publicly available information

Amir Almasi-Hashiani

Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2021 in European Journal of Preventive Cardiology
Verified
Journal Article
Open access
PDF file
SSSaeid Safiri
Saeid Safiri
NKNahid Karamzad
Nahid Karamzad
KSKuljit Singh
Kuljit Singh
KCKristin Carson-Chahhoud
Kristin Carson-Chahhoud
CACobi Adams
Cobi Adams
AKAli-Asghar Kolahi
Ali-Asghar Kolahi
Aims: To report the prevalence, deaths, and disability-adjusted life years (DALYs) associated with ischemic heart disease (IHD) and its attributable risk factors in 204 countries and territories from 1990 to 2019, by age, sex, and socio-demographic index (SDI). Methods and results: Ischemic heart disease was defined as acute myocardial infarction (MI) and chronic IHD (angina; asymptomatic IHD following MI). Cause of death ensemble modelling was used to produce fatality estimates. The prevalence of the non-fatal sequalae of IHD was estimated using DisMod MR 2.1. All estimates were presented as counts and age-standardized rates per 100 000 population. In 2019, IHD accounted for 197.2 million (177.7–219.5) prevalent cases, 9.1 million (8.4–9.7) deaths, and 182.0 million (170.2–193.5) DALYs worldwide. There were decreases in the global age-standardized prevalence rates of IHD [−4.6% (−5.7, −3.6)], deaths [−30.8% (−34.8, −27.2)], and DALYs [−28.6% (−33.3, −24.2)] from 1990 to 2019. In 2019, the global prevalence and death rates of IHD were higher among males across all age groups, while the death rate peaked in the oldest group for both sexes. A negative association was found between the age-standardized DALY rates and SDI. Globally, high systolic blood pressure (54.6%), high low-density lipoprotein cholesterol (46.6%), and smoking (23.9%) were the three largest contributors to the DALYs attributable to IHD. Conclusion: Although the global age-standardized prevalence, death, and DALY rates all decreased. Prevention and control programmes should be implemented to reduce population exposure to risk factors, reduce the risk of IHD in high-risk populations, and provide appropriate care for communities.

1 January 2019 in Pharmacological Research
Verified
Journal Article
Closed access
MSMahdi Sepidarkish
Mahdi Sepidarkish
FFFarnaz Farsi
Farnaz Farsi
MAMaryam Akbari-Fakhrabadi
Maryam Akbari-Fakhrabadi
NNNazli Namazi
Nazli Namazi
AAAmir Almasi-Hashiani
Amir Almasi-Hashiani
MJMojgan Javad
Mojgan Javad

9 September 2019 in Reproductive Health
Verified
Journal Article
Open access
PDF file
SMSaman Maroufizadeh
Saman Maroufizadeh
ROReza Omani-Samani
Reza Omani-Samani
AAAmir Almasi-Hashiani
Amir Almasi-Hashiani
PAPayam Amini
Payam Amini
MSMahdi Sepidarkish
Mahdi Sepidarkish
Background: Depression in patients with infertility often goes undiagnosed and untreated. The Patient Health Questionnaire-9 (PHQ-9) and its ultra-brief version (i.e. PHQ-2) are widely used measures of depressive symptoms. These scales have not been validated in patients with infertility. The aim of the present study was to examine the reliability and validity of the PHQ-9 and PHQ-2 in patients with infertility. Methods: In this cross-sectional study, a total of 539 patients with infertility from a referral infertility clinic in Tehran, Iran completed the PHQ-9, along with other relevant scales: the WHO-five Well-being Index (WHO-5), the Hospital Anxiety and Depression Scale (HADS), and the Generalized Anxiety Disorder-7 (GAD-7). Factor structure and internal consistency of PHQ-9 were examined via confirmatory factor analysis (CFA) and Cronbach’s alpha, respectively. Convergent validity was evaluated by relationship with WHO-5, HADS and GAD-7. Results: The mean total PHQ-9 and PHQ-2 scores were 8.47 ± 6.17 and 2.42 ± 1.86, respectively, and using a cut-off value of 10 (for PHQ-9) and 3 (for PHQ-2), the prevalence of depressive symptoms was 38.6 and 43.6%, respectively. The Cronbach’s alphas for PHQ-9 and PHQ-2 were, respectively, 0.851 and 0.767, indicating good internal consistency. The CFA results confirmed the one-factor model of the PHQ-9 (χ2/df = 4.29; CFI = 0.98; RMSEA = 0.078 and SRMR = 0.044). Both PHQ-9 and PHQ-2 showed moderate to strong correlation with the measures of WHO-5, HADS-depression, HADS-anxiety, and the GAD-7, confirming convergent validity. In univariate analysis, female sex, long infertility duration, and unsuccessful treatment were significantly associated with depression symptoms. Conclusion: Both PHQ-9 and PHQ-2 are brief and easy to use measures of depressive symptoms with good psychometric properties that appear suitable for routine use in patients with infertility.

1 October 2018 in Menopause
Verified
Journal Article
Closed access
PDF file
JHJamal Hallajzadeh
Jamal Hallajzadeh
MKMaliheh Khoramdad
Maliheh Khoramdad
NINeda Izadi
Neda Izadi
NKNahid Karamzad
Nahid Karamzad
AAAmir Almasi-Hashiani
Amir Almasi-Hashiani
SSSaeid Safiri
Saeid Safiri
Objectives: To perform a meta-analysis on the global prevalence of metabolic syndrome (MetS) in postmenopausal women. The meta-analysis also sought to measure the relationship menopause status has with MetS and its components. Methods: The Web of Science, Medline, PubMed, Scopus, Embase, CINAHL, DOAJ, and Google Scholar were all searched using the relevant keywords. Articles published during the period 2004 to 2017 that met our inclusion criteria and reported the prevalence of MetS among premenopausal and postmenopausal women were included. In the presence of heterogeneity, random-effects models were used to pool the prevalence and odds ratios (ORs), as measures of association in cross-sectional and comparative cross-sectional studies, respectively. Results: The prevalence of MetS among postmenopausal women (119 studies [n = 95,115]) and the OR comparing the prevalence of MetS among postmenopausal and premenopausal women (23 studies [n = 66,801]) were pooled separately. The pooled prevalence of MetS among postmenopausal women was found to be 37.17% (95% confidence interval [CI] 35.00%–39.31%), but varied from 13.60% (95% CI 13.55%–13.64%) to 46.00% (95% CI 1.90%–90.09%), depending upon the diagnostic criteria used. The overall pooled OR for MetS in postmenopausal women, compared with premenopausal women, was OR 3.54 (95% CI 2.92-4.30), but this ranged from OR 2.74 (95% CI 1.32-5.66) to OR 5.03 (95% CI 2.25-11.22), depending upon the criteria used. Furthermore, the odds of high fasting blood sugar (OR 3.51, 95% CI 2.11-5.83), low high-density lipoprotein cholesterol (OR 1.45, 95% CI 1.03-2.03), high blood pressure (OR 3.95, 95% CI 2.01-7.78), high triglycerides (OR 3.2, 95% CI 2.37-4.31), and high waist circumference (OR 2.75, 95% CI 1.80-4.21) were all found to be higher in postmenopausal women than in premenopausal women. Conclusions: The prevalence of MetS is relatively high in postmenopausal women and was more prevalent among postmenopausal than premenopausal women. Menopausal hormone therapy should be used with caution in patients with MetS, as its safety has not yet been evaluated among MetS patients and meticulous evaluation of each individual patient before starting MHT is needed.

1 April 2019 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
ZCZahra Cheraghi
Zahra Cheraghi
ADAmin Doosti-Irani
Amin Doosti-Irani
AAAmir Almasi-Hashiani
Amir Almasi-Hashiani
VBVali Baigi
Vali Baigi
NMNasrin Mansournia
Nasrin Mansournia
MMMohammad Ali Mansournia
Mohammad Ali Mansournia

1 July 2011 in Indian Journal of Psychological Medicine
Verified
Journal Article
Open access
PDF file
FGFarhad Ghamari
Farhad Ghamari
AMAbolfazl Mohammadbeigi
Abolfazl Mohammadbeigi
NMNarges Mohammadsalehi
Narges Mohammadsalehi
AHAmir Almasi Hashiani
Amir Almasi Hashiani
Background : Today's internet is a usual and common method for identifying and fulfilling unknown practices. Internet network has been prepared rapid and comfortable access to information. Internet addiction is a new and attractive subject that has been regarded as behavior-based addiction recently. Purpose : To estimate the prevalence of internet addiction and some of the related factors among medical students, Iran. Materials and Methods : An analytical cross-sectional study was conducted on 426 students selected through two-stage sampling method. Yang standard internet addiction questionnaire was used for data collection. After data entry, χ 2 , t-test, and Pearson coefficient statistical tests were applied. 0.05 was considered as the significance level. Results : The overall prevalence of internet addiction was 10.8%, with moderate and severe internet addiction equal to 8% and 2.8%, respectively. Mean and standard deviation of Yang internet addiction score was calculated as 32.74±14.52. Internet addiction was associated with sex, marital status, father's job, rate of knowledge about computer and internet, and educational level (P0.05). Conclusion : Because internet addiction leads to wasting of the students' leisure time and also useful time, it affects the educational situation inversely. Some measures should be taken to plan and improve the use of internet.